Evidence map›Paper›PMID 42316425›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026

The include network: Advancing cross-linguistic equity in brain health research.

Adolfo M García, Jessica de Leon, Suvarna Alladi, Petronilla Battista, Agustina Birba, Stefano F Cappa, Bárbara Costa Beber, Jessica Jiang, David Kemmerer, Maxime Montembeault and 4 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Adolfo M GarcíaCognitive Neuroscience Center, Department of Life and Behavioral Sciences, Universidad de San Andrés, Buenos Aires, Argentina.
Jessica de LeonWeill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA.
Suvarna AlladiNational Institute of Mental Health and Neurosciences, Bengaluru, India.
Petronilla BattistaLaboratory of Neuropsychology, Istituti Clinici Scientifici Maugeri IRCCS, Institute of Bari, Bari, Italy.
Agustina BirbaCognitive Neuroscience Center, Department of Life and Behavioral Sciences, Universidad de San Andrés, Buenos Aires, Argentina.
Stefano F CappaUniversity School for Advanced Studies (IUSS-Pavia), Milan, Italy.
Bárbara Costa BeberGraduate Program in Rehabilitation Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.
Jessica JiangDementia Research Centre, Queen Square Institute of Neurology, University College London, London, UK.
David KemmererDepartment of Speech, Language, and Hearing Science, Purdue University, West Lafayette, Indiana, USA.
Maxime MontembeaultDouglas Research Centre, Montreal, Quebec, Canada.
Juan Rafael Orozco-ArroyaveGITA Lab. Faculty of Engineering, University of Antioquia, Medellín, Colombia.
Maria Luisa Gorno-TempiniWeill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA.
Boon Lead TeeWeill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA.
Include Network

Funding

An automated machine learning approach to language changes in Alzheimer’s disease and frontotemporal dementia across Latino and English-speaking populationsR01AG075775 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARIA LUISA GORNO TEMPINI, Adolfo Martin Garcia · 2023 to 2026
$7.2M
US-South American Initiative for Genetic-Neural-Behavioral Interactions in Human Neurodegenerative ResearchR01AG057234 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Claudia Duran-Aniotz, Agustin M. Ibanez · 2019 to 2026
$6.1M
Circadian Disturbance and Dementia in Latin AmericaR01AG083799 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Kun Hu, Agustin M. Ibanez · 2023 to 2026
$3.0M
Training program in the neurology of language and neurodegenerative aphasiasK24DC015544 · NIDCD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GORNO TEMPINI, MARIA LUISA · 2016 to 2025
$1.9M
Agencia Nacional de Investigación y Desarrollo FONDECYT Regular 1250091Agencia Nacional de Promoción Científica y Tecnológica 01-PICTE-2022-05-00103Alzheimer SocietyANID (FONDECYT Regular 1250317 1250091CIHRDBTDSTFonds de Recherche du Québec - SantéFundação de Amparo à Pesquisa do Estado do Rio Grande do SulHealthy Brains Healthy LivesICMRMinistero della Salute Project-ID PNRR- MCNT2-2023-12378220NIA-NIH 223316NIA-NIH 2P01AG019724-21A1NIA-NIH Swiss National Science Foundation SwitzerlandNIA NIH HHS 2P01AG019724NIA NIH HHS R01 AG057234NIA NIH HHS R01 AG075775NIA NIH HHS R01 AG083799NIDCD NIH HHS K24 DC015544NIH HHSSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 223316the Alzheimer's Association GBHI ALZ UK-22-866347the Italian Ministry of Health ID PNRR- MCNT2-2023-12378220the National Institutes of Health 2P01AG019724the National Institutes of Health R01AG075775the National Institutes of Health R01AG083799Universidad de Antioquia
6 · The paper itself

Abstract

Speech and language measures are increasingly recognized as sensitive, scalable, non-invasive markers of diverse brain disorders. Yet, current research is overwhelmingly English-centric, neglecting the world's vast linguistic diversity and undermining these markers' global applicability. Here we present the International Network for Cross-Linguistic Research on Brain Health (Include), a multicentric initiative created to address this gap (https://include-network.com/). First, we review the network's origins, mission, and organizational structure. Then, we summarize key milestones achieved during its first 4 years, spanning cross-linguistic empirical studies, harmonized data-governance frameworks, and global dissemination efforts. We further highlight flagship projects demonstrating how linguistic typology and culture shape speech-language markers of neurodegeneration. Finally, we outline critical challenges and opportunities for the field, focusing on language underrepresentation, tool harmonization, regulatory heterogeneity, and expansion beyond neurodegeneration. Together, these efforts position Include as a strategic platform for fostering equitable, globally relevant brain-health research.

Indexed as

Biomedical ResearchBrainLanguageLinguisticsHumansbrain healthcross‐linguistic researchglobal equityneurodegenerationspeech and language markers

Identifiers

PMID42316425
PMCPMC13279474

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.